Seres Therapeutics (MCRB) IPO Prices at $18, Above Expected Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Seres Therapeutics (MCRB) IPO Down 17% after Friday's 180% Surge
June 29, 2015 10:03 AM EDTLast week's red hot IPO for Seres Therapeutics (NASDAQ: MCRB) is under heavy pressure Monday. After pricing at $18 and closing its first day of trading up 180% to $51.40, shares are down 17.6% to $42.35 today.
... MoreSeres Therapeutics (MCRB) IPO Opens Up 58%
June 26, 2015 11:53 AM EDTToday's IPO for Seres Therapeutics, Inc. (NASDAQ: MCRB) opened for trading at $28.50 after pricing 7,430,555 shares of common stock at a public offering price of $18.00 per share, above the expected $15-$17 range.
In addition, Seres Therapeutics granted the underwriters a 30-day option to... More
